Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus